Wegovy vs Zepbound: Weight Loss, Side Effects & Cost Compared

Last updated: October 24, 2026

Quick Answer

Zepbound (tirzepatide) produces more weight loss than Wegovy (semaglutide) for most patients because it targets two gut hormone pathways instead of one. In a head-to-head trial, Zepbound users lost significantly more body weight than Wegovy users over 72 weeks [1][2]. Wegovy still holds an edge in certain heart-health and younger-patient approvals, and both drugs carry similar costs before insurance. Your choice depends on your weight-loss goals, tolerance for side effects, and what your insurance actually covers.

In the Wegovy vs Zepbound: Weight Loss, Side Effects & Cost Compared debate, the short version is this: Zepbound wins on raw pounds lost, Wegovy wins on cardiovascular and pediatric label breadth, and pricing is close enough that insurance coverage usually decides the winner for your wallet.

Key Takeaways

• Zepbound outperformed Wegovy in a direct 2025 clinical trial, with patients losing roughly 50% more body weight on average [1][2].
• Both drugs are once-weekly injections approved for chronic weight management in adults with obesity or overweight plus a health condition [3].
• Nausea, vomiting, diarrhea, and constipation are the most common side effects for both, though Zepbound’s GI complaints can hit slightly differently due to its dual mechanism.
• Wegovy has FDA approval for reducing cardiovascular risk and for adolescents 12 and older; Zepbound is adult-only [3].
• List prices for both drugs run similarly high without insurance, though actual self-pay programs can lower costs for eligible patients.
• Stopping either drug typically leads to weight regain unless paired with ongoing lifestyle changes.
• Switching between the two is possible under medical supervision, but it’s not a simple one-to-one dose swap.

What’s the Difference Between Wegovy and Zepbound

Wegovy contains semaglutide, a GLP-1 receptor agonist. Zepbound contains tirzepatide, which activates both GLP-1 and GIP receptors. That second pathway is the core difference driving Zepbound’s stronger average results.

Both medications are injected once a week using a prefilled pen, and both work by slowing digestion and telling your brain you’re full. But Zepbound’s dual-hormone action appears to amplify appetite suppression and improve insulin sensitivity more than semaglutide alone [4][5]. Think of Wegovy as a strong single-key appetite suppressor, and Zepbound as a two-key version that locks down hunger from more angles.

Choose Wegovy if you’ve had cardiovascular events and want an FDA-approved option specifically studied for heart risk reduction. Choose Zepbound if maximum weight loss is your top priority and you don’t have a competing cardiovascular indication guiding your care team’s choice.

Which Drug Causes More Weight Loss: Wegovy or Zepbound

Zepbound causes more weight loss than Wegovy in nearly every comparison, including the direct head-to-head study designed to settle this question. In the SURMOUNT-5 trial, Zepbound patients lost an average of 20.2% of body weight compared to 13.7% for Wegovy patients over 72 weeks [1][2].

That’s not a small gap. Eli Lilly’s own trial data show Zepbound patients were also far more likely to hit major weight-loss milestones:

• More than twice as many Zepbound patients lost at least 25% of their body weight compared to Wegovy patients [2][5].
• A meaningfully larger share of Zepbound users reached the 20% weight-loss threshold [1].
• Zepbound’s own placebo-controlled obesity trials showed strong, dose-dependent results, with higher doses producing greater losses [4][6].

Typical Zepbound results break down roughly like this, based on updated dose-range analyses:

Zepbound dose	Approximate average weight loss
5 mg	Lower end of range
10 mg	Moderate, mid-range results
15 mg (max)	Highest average weight loss reported

Mistake to avoid: don’t assume a higher number on a chart guarantees your personal result. Individual response varies with starting weight, adherence, diet, and dose tolerance. Some people lose more on Wegovy than the “average” Zepbound patient, especially if they can’t tolerate higher tirzepatide doses.

How Much Does Wegovy Cost With Insurance vs Zepbound

Insurance coverage, not the sticker price, usually decides which drug is cheaper for you. Both Wegovy and Zepbound carry similarly high list prices before insurance, and coverage varies heavily by plan, employer, and state Medicaid rules.

Key cost factors to check before picking a drug:

1. Does your plan have a weight-management drug benefit at all? Many still exclude GLP-1s for obesity-only diagnoses.
2. Is prior authorization required, and what BMI or comorbidity threshold do you need to qualify?
3. Does the manufacturer offer a savings card, and are you eligible (commercially insured patients usually qualify more easily than those on Medicare or Medicaid)?
4. What’s your deductible and copay tier for specialty injectables?

If your insurer only covers one of the two drugs, that answer often matters more than the clinical weight-loss edge. For a deeper breakdown of what GLP-1 therapy typically costs across providers, see our guide on GLP-1 weight loss cost.

Is It Cheaper to Buy Zepbound or Wegovy Without Insurance

Without insurance, both drugs are expensive, and neither is reliably “cheaper” in a way that holds steady over time, since list prices and self-pay programs both shift. According to Drugs.com pricing data updated in mid-October 2026, self-pay costs for both medications remain in a similar high range per month [VERIFY: check current Drugs.com listing for exact current price, as list prices change periodically].

Practical ways to lower out-of-pocket costs:

• Ask your prescriber about manufacturer self-pay or cash-pay savings programs, which sometimes reduce monthly cost substantially for eligible patients.
• Compare telehealth providers, since some bundle the medication with lower-cost provider visits.
• Review lower-dose starter pricing versus maintenance-dose pricing, since starter doses are sometimes discounted.

If cost is your primary barrier, it’s worth reading our comparison of cheap weight loss injections and GLP-1 shots before committing to either brand.

What Are the Worst Side Effects of These Medications

The most serious side effects for both drugs include pancreatitis, gallbladder problems, kidney issues from dehydration, and, in rare cases, severe allergic reactions. Both carry warnings about thyroid C-cell tumors seen in animal studies, which is why neither drug is recommended for people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

Common, less severe side effects overlap heavily between the two:

• Nausea, especially during dose increases
• Vomiting and diarrhea
• Constipation
• Fatigue
• Injection site reactions

Zepbound’s dual mechanism can mean a different intensity of GI symptoms for some patients, and dose titration speed is often the real driver of how rough the side effects feel, more than which drug you’re on. Common mistake: jumping doses too fast because you’re impatient for results. Slower titration almost always reduces nausea and vomiting severity.

Seek medical help immediately for severe abdominal pain (possible pancreatitis), vision changes, signs of a severe allergic reaction, or a lump in the neck.

Who Shouldn’t Take Wegovy or Zepbound

Neither drug is appropriate for people with a personal or family history of medullary thyroid cancer, MEN 2 syndrome, or a known serious allergy to the medication’s ingredients. Pregnant or breastfeeding individuals should also avoid both.

Additional considerations:

• Zepbound is approved only for adults; it is not labeled for anyone under 18 [3].
• Wegovy has pediatric approval starting at age 12, giving families with teens a legally approved option Zepbound doesn’t offer [3].
• People with a history of severe gastroparesis or significant GI motility disorders should discuss risk carefully with their prescriber, since both drugs slow gastric emptying.
• Anyone with a history of suicidal thoughts should discuss mental health monitoring with their provider before starting either drug.

Decision rule: if you’re treating a teenager or need a cardiovascular-risk-reduction indication, Wegovy is currently the only FDA-approved choice between the two for those specific needs [3].

Why Isn’t My Wegovy Working Anymore

If Wegovy stops working, the most common causes are a dose that’s too low for your current weight, a weight-loss plateau your body naturally hits, or lifestyle habits that have slipped. This happens to many patients around month four to six, and it doesn’t always mean treatment failure.

Steps to troubleshoot before giving up:

1. Confirm you’re on the correct maintenance dose; some people stall at a dose below 2.4 mg and need a provider-guided increase.
2. Review your injection technique and storage, since improperly stored pens can lose potency.
3. Track your food intake honestly; appetite suppression can mask gradual calorie creep from liquid calories or snacking.
4. Ask your provider whether switching to Zepbound makes sense if you’ve maxed out your Wegovy dose and plateaued.

Plateaus are also biologically normal. Your metabolism adjusts as you lose weight, so the same calorie intake burns less. This is an edge case worth discussing with a provider rather than assuming the drug has simply “failed.”

Can You Switch From Wegovy to Zepbound

Yes, switching from Wegovy to Zepbound is medically possible and fairly common when someone plateaus or experiences side effects on semaglutide. It should be done under a prescriber’s guidance rather than self-directed, since dosing isn’t a direct one-to-one conversion.

What typically happens during a switch:

• Your provider usually starts you on a low Zepbound dose (often 2.5 mg) regardless of your prior Wegovy dose, to assess tolerance.
• You’ll go through a titration schedule again, even if you were at a high Wegovy dose.
• Insurance may require a new prior authorization, since the two drugs are made by different manufacturers.

Common mistake: assuming you can jump straight to a high Zepbound dose because you tolerated a high Wegovy dose well. The mechanisms differ enough that restarting titration is the safer, standard approach.

Do You Gain the Weight Back After Stopping These Medications

Most people regain a significant portion of lost weight after stopping either drug, unless they’ve built lasting changes to diet, activity, and behavior during treatment. This is a well-documented pattern across GLP-1 research and is not unique to one brand over the other.

Why this happens:

• Appetite-regulating hormones return to baseline once the medication clears your system.
• Obesity is increasingly understood as a chronic condition, meaning many patients need long-term or indefinite treatment, similar to how blood pressure medication works.
• Rapid stopping without a tapering or maintenance plan tends to produce faster regain than a planned transition to lower maintenance dosing.

If you’re considering stopping, talk to your provider about a maintenance-dose strategy rather than abrupt discontinuation. For more on building habits that support results during and after treatment, our guide on semaglutide weight loss results covers real-world patterns worth reviewing.

How Long Do You Have to Stay on Zepbound or Wegovy

Most patients stay on these medications long-term, often a year or more, because obesity treatment guidelines increasingly treat these drugs as chronic maintenance therapy rather than a short course. There’s no fixed “finish line” built into either drug’s labeling.

Factors that influence duration:

• How you respond: patients who tolerate the drug well and keep losing or maintaining weight often continue indefinitely.
• Side effect burden: persistent GI issues sometimes lead to dose adjustments rather than full discontinuation.
• Cost and insurance renewal cycles, which can force interruptions even when the drug is working well.
• Personal goals, such as reaching a target weight before transitioning to a lower maintenance dose.

Decision rule: if you’ve reached your goal weight and want to stop, ask your provider about a gradual dose reduction plan instead of quitting outright, since this tends to blunt rebound weight gain better than cold-turkey stopping.

What Common Mistakes Do People Make When Using These Drugs

The most common mistakes are skipping doses inconsistently, increasing doses too fast, and expecting the drug to work without any dietary adjustment. Each of these undermines both safety and results.

Frequent errors to avoid:

• Taking the injection on a different day each week instead of a consistent weekly schedule, which can cause uneven blood levels and more side effects.
• Eating large, high-fat meals during the nausea-prone titration period, which worsens GI symptoms.
• Not drinking enough water, increasing risk of dehydration-related kidney strain.
• Stopping the drug the moment weight loss slows instead of discussing dose adjustments with a provider.
• Comparing your results to someone else’s trial-level averages instead of tracking your own trend over weeks.

Are There Other Weight Loss Drugs as Good as These Two

A few other GLP-1 and related medications offer meaningful weight loss, though none have outperformed Zepbound in head-to-head obesity trials published so far. Options worth knowing about include older GLP-1 drugs and oral alternatives for patients who prefer not to inject or who don’t tolerate semaglutide or tirzepatide.

Alternatives patients often ask about:

• Saxenda (liraglutide), an older daily GLP-1 injection with a longer safety track record but generally lower average weight loss.
• Oral semaglutide formulations, useful for needle-averse patients; see our comparison of semaglutide dose options, injections versus oral tablets.
• Byetta and Bydureon, earlier-generation GLP-1 drugs mainly used for diabetes management rather than weight loss as a primary goal; see our Byetta review and Bydureon review for context.

For a full breakdown across seven major options, our guide on which GLP-1 is best for weight loss in 2026 lays out the comparisons side by side. You may also find it useful to read our detailed semaglutide vs tirzepatide comparison for the mechanism-level differences behind these results.

Can You Take Both Wegovy and Zepbound at the Same Time

No, you should never take Wegovy and Zepbound simultaneously. Both drugs act on overlapping hormone pathways, and combining them significantly raises the risk of severe side effects, including dangerous GI complications and pancreatitis, without any established benefit.

If you’re transitioning between the two, your provider will have you fully stop one before starting the other, typically after a short washout period they’ll determine based on your specific health history. There is no clinical evidence or FDA guidance supporting concurrent use of both drugs.

What’s the Fastest Weight Loss Results Between the Two

Zepbound tends to produce faster early weight loss than Wegovy, largely because its dual mechanism suppresses appetite more aggressively from the start of treatment. Patients in the head-to-head trial showed a wider separation in results as the 72-week period progressed, with Zepbound’s advantage becoming more pronounced over time rather than only showing up early [1][2].

That said, “fastest” isn’t always “best” for every patient. Faster appetite suppression can also mean more intense early nausea for some people, which occasionally leads to slower titration schedules that offset the speed advantage. Your actual pace of results depends on starting dose, how quickly you titrate, and your individual metabolic response.

Wegovy vs Zepbound: Weight Loss, Side Effects & Cost Compared at a Glance

Factor	Wegovy (semaglutide)	Zepbound (tirzepatide)
Mechanism	GLP-1 receptor agonist	Dual GLP-1/GIP receptor agonist
Average weight loss (head-to-head trial)	13.7% of body weight [1]	20.2% of body weight [1]
Approved age range	12 and older [3]	Adults only [3]
Cardiovascular risk reduction label	Yes [3]	Not currently labeled for this
Common side effects	Nausea, vomiting, diarrhea, constipation	Nausea, vomiting, diarrhea, constipation
Self-pay cost range	High; varies by pharmacy [VERIFY current pricing]	High; similar range [VERIFY current pricing]

FAQ

Is Zepbound really more effective than Wegovy? Yes, in the head-to-head SURMOUNT-5 trial, Zepbound patients lost more weight on average than Wegovy patients, 20.2% versus 13.7% of body weight [1][2].

Which drug has worse side effects? Both drugs share similar GI side effects like nausea and constipation. Neither is clearly “worse” overall; tolerability varies by individual and by how fast the dose is increased.

Can I switch from Zepbound back to Wegovy? Yes, switching in either direction is possible with a provider’s guidance, though you’ll likely restart at a low dose and retitrate.

Does insurance cover Zepbound more than Wegovy, or vice versa? Coverage depends entirely on your specific insurance plan and formulary, not a universal rule. Always check your plan’s current drug list before assuming either is “the covered one.”

Will I regain weight after stopping either drug? Most patients regain a meaningful portion of lost weight after stopping, since both drugs treat obesity as an ongoing condition rather than a one-time fix.

Is Zepbound safe for teenagers? No, Zepbound is approved for adults only. Wegovy has pediatric approval starting at age 12 [3].

How fast will I see results on either drug? Noticeable appetite changes often appear within the first few weeks, but meaningful weight loss typically builds over several months as you reach your maintenance dose.

Can I take Ozempic instead of Wegovy or Zepbound for weight loss? Ozempic is FDA-approved for type 2 diabetes, not weight management, though it contains the same active ingredient as Wegovy. Ask your provider which approved option fits your diagnosis.

Conclusion

Zepbound generally produces greater weight loss than Wegovy, backed by direct head-to-head trial data showing a meaningful gap in average results [1][2]. Wegovy still holds unique value for cardiovascular risk reduction and for younger patients, and side effect profiles between the two are close enough that your personal tolerance matters more than brand. Cost comes down to your specific insurance coverage far more than any fixed price difference between the drugs. Before choosing either, talk with your provider about your health history, your insurance formulary, and realistic expectations for long-term use. If you want to compare broader GLP-1 options and costs before deciding, explore our guide on best GLP-1 medication approved for weight loss as your next step.

This article is for informational purposes only and is not medical advice. Talk to a licensed healthcare provider before starting or changing any medication.

References

1. Zepbound Outduels Wegovy Weight Loss Clinical Trial. news.cornell.edu.
2. Zepbound Tirzepatide Showed Superior Weight Loss Over Wegovy. investor.lilly.com.
3. FDA Approves New Medication Chronic Weight Management. fda.gov.
4. Clinical Data Weight. zepbound.lilly.com.
5. Lillys Zepboundr Tirzepatide Superior Wegovyr Semaglutide Head. investor.lilly.com.
6. How Weight Lose Zepbound 3575539. drugs.com.